Conversely, concurrent knockdown of FGFR1 and VEGFR3 recapitulated the targeted drug‐resistant phenotype and abolished downstream signaling in MCB1 knockdown hepatoma cells, while knockdown of either of them showed a limited effect (Figure 6J–L; Figure S9F–J, Supporting Information). Here, FLT4 is linked to hepatocellular carcinoma.